These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 470233)

  • 21. [Various indicators of the anticoagulation system in children with chronic glomerulonephritis].
    Zakharchenko LP
    Vopr Okhr Materin Det; 1976 Aug; 21(8):41-4. PubMed ID: 997365
    [No Abstract]   [Full Text] [Related]  

  • 22. Exploration of intraglomerular phenomena by measurement of the level of fibrin degradation products in the renal vein blood.
    Conte J; Boneu B; Mignon-Conte ; Suc JM
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):915-26. PubMed ID: 4807811
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of fibrin-fibrinogenolysis on the determination of the fibrinogen content and fibrin-fibrinogen degradation products (FDP) by means of the fibrin polymerization time (FPT test)].
    Vorlová Z; Dyr IE
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):967-70. PubMed ID: 94893
    [No Abstract]   [Full Text] [Related]  

  • 24. [Standarization of the staphylococcal clumping test (SCT) for the detection of fibrinogen/fibrin degradation products (FDP) in serum (author's transl)].
    Contreras P; Salazar R
    Rev Med Chil; 1975 Aug; 103(8):551-4. PubMed ID: 1197971
    [No Abstract]   [Full Text] [Related]  

  • 25. [Blood coagulation and fibrinolysis in patients with renal diseases (author's transl)].
    Yamabe H
    Nihon Jinzo Gakkai Shi; 1979 May; 21(3):219-31. PubMed ID: 470232
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparative study of various rapid methods of determining fibrinogen transformation products in the diagnosis of intravascular coagulation and fibrinolysis].
    Lychev VG; Momot AP; Cherkashin GV
    Ter Arkh; 1984; 56(6):106-9. PubMed ID: 6474366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrinolysis in glomerulonephritis treated with ancrod: renal functional, immunologic and histopathologic effects.
    Kim S; Wadhwa NK; Kant KS; Pollak VE; Glas-Greenwalt P; Weiss MA; Hong CG
    Q J Med; 1988 Nov; 69(259):879-905. PubMed ID: 3078212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of anesthesia and surgery on serum and urinary fibrinogen/fibrin degradation products (FDP) levels in man (author's transl)].
    Shinozaki Y; Takiguchi M; Oyama T
    Masui; 1978 Mar; 27(3):253-9. PubMed ID: 650865
    [No Abstract]   [Full Text] [Related]  

  • 29. [Detection of fibrin degradation products in renal diseases in children].
    Mancini AF; Rosito P; Mei V; Tazzari R
    Minerva Pediatr; 1977 Apr; 29(15):1047-54. PubMed ID: 875983
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunoenzyme determination of fibrin-fibrinogen degradation product levels in acute myocardial infarct patients].
    Grinshteĭn IA; Ignashenkova GV; Kitaev MI
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):18-21. PubMed ID: 3300697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Determination of plasma fibrinogen and fibrin degradation products (FDP) in 100 normal persons and 32 cases of acute cerebrovascular disease (author's transl)].
    Wang GX
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 Feb; 15(1):8-10. PubMed ID: 7094732
    [No Abstract]   [Full Text] [Related]  

  • 32. Renal disease and fibrinogen degradation products.
    Hedner U; Nilsson IM
    Adv Nephrol Necker Hosp; 1974; 3():241-71. PubMed ID: 4219704
    [No Abstract]   [Full Text] [Related]  

  • 33. [The inhibition of coagulation in cord plasma (author's transl)].
    Kirchhof BR; Hoheisel M; Keefer L; Hemker HC
    Z Geburtshilfe Perinatol; 1979 Apr; 183(2):163-8. PubMed ID: 442731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coagulation and fibrinolytic properties of peripheral venous blood in chronic ectopic pregnancy.
    Carty MJ; Barr RD; Ouna N
    S Afr Med J; 1976 Jul; 50(29):1147-8. PubMed ID: 959930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary fibrin degradation products in childhood acute nephritis.
    Dawson KP
    N Z Med J; 1977 Oct; 86(597):332-4. PubMed ID: 272538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of urinary fibrin/fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases.
    Shibata T; Magari Y; Kamberi P; Ishii T; Tomo T; Yasumori R; Nasu M
    Clin Nephrol; 1995 Aug; 44(2):91-5. PubMed ID: 8529315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The usefullness of the fibrinogen degradation products (FDP) determination in the serum and urine in diagnostics and evaluation of effectiveness of therapy of nephropathy (author's transl)].
    Kwiecien-Głowacka E
    Przegl Lek; 1981; 38(3):335-40. PubMed ID: 7244292
    [No Abstract]   [Full Text] [Related]  

  • 38. [Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].
    Heene DL; Genth K
    Internist (Berl); 1984 Feb; 25(2):93-101. PubMed ID: 6231262
    [No Abstract]   [Full Text] [Related]  

  • 39. [Critical evaluation of new methods for studying fibrin degradation products].
    Prisco D
    Recenti Prog Med; 1989 May; 80(5):263-7. PubMed ID: 2669062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study on coagulation fibrinolytic systems in predialysis patients with chronic renal failure--comparison between patients with chronic glomerulonephritis and patients with diabetic nephropathy].
    Nagake Y; Makino H; Yorioka N; Nomura S; Osawa G; Yamakido M; Kawasaki H; Kato Y; Matsuzaki M; Shikata K; Uemasu J; Somiya H; Fujii Z; Hayashida S; Nasu T; Oyabu Y; Nitta Y; Kawanishi H; Usui K; Fujiwara K; Takasugi N; Kanehara K; Hamaguchi N; Kumagai I; Ota Z
    Nihon Jinzo Gakkai Shi; 1997 Jul; 39(5):474-82. PubMed ID: 9283213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.